M. Bahjat

发表

Systems Biology Approach Identifies the Kinase Csnk1a1 as a Regulator of the DNA Damage Response in Embryonic Stem Cells

Jesper V Olsen, Bob van de Water, Harry Vrieling, 2013, Science Signaling.

Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)

E. Stroes, S. Tsimikas, J. Kroon, 2020, European heart journal.

The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph+ leukemia and sensitizes for ABL kinase inhibitors

M. Kersten, R. Bende, J. Guikema, 2019, Cell cycle.

BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes

S. Wasiak, N. Wong, B. Rakai, 2020, Clinical Epigenetics.

LYMPHOID NEOPLASIA NF- k B and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity

R. Bende, J. Guikema, C. Noesel, 2015 .

NF-κB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity.

R. Bende, A. M. de Bruin, J. Guikema, 2015, Blood.

The Complex Interplay between DNA Injury and Repair in Enzymatically Induced Mutagenesis and DNA Damage in B Lymphocytes

J. Guikema, M. Bahjat, 2017, International journal of molecular sciences.

DNA polymerase β prevents AID-instigated mutagenic non-canonical mismatch DNA repair

R. Bende, J. Guikema, C. V. van Noesel, 2020, bioRxiv.

The DNA Damage Response Regulates RAG1/2 Expression in Pre–B Cells through ATM-FOXO1 Signaling

R. Bende, C. E. Schrader, A. M. de Bruin, 2016, The Journal of Immunology.

Potential epigenetic therapeutics for atherosclerosis treatment.

E. Stroes, M. D. de Winther, M. Bahjat, 2019, Atherosclerosis.

NF-κB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity.

R. Bende, A. M. de Bruin, J. Guikema, 2015, Blood.